Medicare said Thursday it’s considering a cut in enrollee premiums after officials stuck with an earlier decision to sharply limit coverage for a pricey new Alzheimer’s drug projected to drive up program costs.
The, Doctor
Merkez mahallesi mutlu han sokak no:17/2 Bartın/Sakarya
info@blognews.com.tr